Atracurium besylate (BW-33A) is a potent, competitive, and non-depolarizing neuromuscular blocking agent. It acts as an AChR receptor antagonist, inducing bronchoconstriction and neuromuscular blockade. This compound also promotes astroglial differentiation, making it suitable for various research applications.
- Potent, competitive, and non-depolarizing neuromuscular blocking agent
- AChR receptor antagonist
- Induces bronchoconstriction and neuromuscular blockade
- Promotes astroglial differentiation
- Purity 98.6%
- Supplied as 10 mM in 1 mL DMSO
- Store at 4°C, sealed, away from moisture; in solvent at -80°C for 6 months or -20°C for 1 month